Zenas BioPharma director gets 18,500 stock options
Zenas BioPharma director Jason Raleigh Nunn was granted stock options for 18,500 shares of Common Stock.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Zenas BioPharma director Jason Raleigh Nunn was granted stock options for 18,500 shares of Common Stock. The options have an exercise price of $18.71 per share and expire on June 15, 2036. They vest entirely on June 15, 2027, contingent on continued service.
Insider Trade Summary
Grant/Award: 18,500 shares
Grant/Award
1 txn
Insider
Nunn Jason Raleigh
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 18,500 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 18,500 contracts (Direct)
Footnotes (1)
- F1. The option vests as to 100% of the underlying shares of common stock on June 15, 2027, the first anniversary of the vesting commencement date, subject to continued service.
Key Figures
Options granted: 18,500 options
Exercise price: $18.71 per share
Shares underlying options: 18,500 shares
+3 more
6 metrics
Options granted
18,500 options
Stock Option (Right to Buy) grant to director
Exercise price
$18.71 per share
Strike price for the 18,500 stock options
Shares underlying options
18,500 shares
Common Stock underlying the derivative security
Expiration date
June 15, 2036
Option expiration for the granted award
Vesting date
June 15, 2027
100% vesting date subject to continued service
Holdings after grant
18,500 derivative securities
Total stock options held after this transaction
Key Terms
Stock Option (Right to Buy), exercise price, expiration date, underlying security, +2 more
6 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
exercise price financial
"conversion_or_exercise_price: "18.7100""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2036-06-15T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
underlying security financial
"underlying_security_title: "Common Stock""
vests as to 100% financial
"The option vests as to 100% of the underlying shares"
derivative security financial
"transaction_type: "derivative""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Zenas BioPharma (ZBIO) director Jason Raleigh Nunn report on this Form 4?
Jason Raleigh Nunn reported receiving a grant of stock options for 18,500 shares of Zenas BioPharma Common Stock. These options are a compensation award, not an open-market purchase or sale of existing shares.
How many Zenas BioPharma (ZBIO) stock options were granted to the director?
The director was granted options covering 18,500 shares of Zenas BioPharma Common Stock. This entire amount represents a single compensation award recorded as a derivative security transaction on the Form 4.
What is the exercise price of the Zenas BioPharma (ZBIO) options granted?
The stock options have an exercise price of $18.71 per share. This means the director can buy Zenas BioPharma Common Stock at $18.71 once the options are vested and exercised, subject to the option terms.
When do the Zenas BioPharma (ZBIO) options granted to the director vest?
The options vest as to 100% of the underlying 18,500 shares on June 15, 2027. Vesting is conditioned on the director’s continued service through that vesting date under the award’s terms.
When do the newly granted Zenas BioPharma (ZBIO) stock options expire?
The granted stock options are scheduled to expire on June 15, 2036. After that expiration date, any unexercised options would no longer be exercisable under the award’s stated terms.
Is this Zenas BioPharma (ZBIO) Form 4 a stock purchase or sale?
No, this Form 4 reflects a grant of stock options as compensation, not a market trade. The transaction code is “A,” indicating a grant, award, or other acquisition of derivative securities rather than an open-market buy or sell.
AI-generated analysis. How Rhea-AI works. Not financial advice.
